← Back to all signals
RESEARCH PAPER ANALYSIS

MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study.

AI interpretation is pending for this paper.

Open original publication →
PMID42547612
JournalMolecular and cellular pediatrics
Publication Date2026-08-04
Ingested2026-08-06 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Prompt diagnosis of childhood acute lymphoblastic leukemia (ALL) remains a clinical challenge, particularly in children presenting with normal blood counts and musculoskeletal symptoms. With the increasing use of magnetic resonance imaging (MRI) in evaluating such complaints, bone marrow signal alterations may be detected before hematologic abnormalities appear. Previous studies have described characteristic MRI patterns in leukemia, suggesting potential for earlier recognition. This study aims to clarify the role of MRI in the diagnostic pathway of pediatric ALL and to define radiological findings that should prompt bone marrow examination. We retrospectively reviewed all patients diagnosed with ALL at our institution between 2006 and 2024 and included those who underwent MRI prior to diagnosis. Clinical data were collected, and all MRI studies were re-evaluated by an experienced pediatric radiologist. RESULTS: Twenty pediatric patients with ALL were included. Due to differing MRI protocols, the cohort was divided into two groups: one group (n = 17) underwent musculoskeletal imaging and one group (n = 3) underwent imaging of the trunk. Overall, MRI-detected bone marrow signal alterations contributed to diagnosis in 20 of 424 (4.7%) newly diagnosed pediatric ALL cases. More than one-third of patients (7/20; 35%) had a completely normal complete blood count (CBC) at presentation. Persistent bone pain was the leading symptom, preceding imaging in 18/20 cases. The mean time from symptom onset to MRI was 20.8 days (range 1-65), while the mean time from MRI to diagnosis was 18.4 days (range 0-180). In the musculoskeletal scans, all patients showed bone marrow signal alterations, predominantly T1-weighted (T1w) hypointensity (17/17) and proton-density-weighted (PDw) or T2-weighted short tau inversion recovery (T2w-STIR) hyperintensity (16/17). In the trunk scans, diffusion-weighted imaging revealed high DWI signal with low ADC values (3/3), and T2-weighted images demonstrated focal lesions (3/3). CONCLUSION: MRI plays an important role in the diagnostic pathway of pediatric ALL, especially in patients with persistent musculoskeletal pain and normal blood counts. In our cohort, MRI examinations could initiate a rapid diagnostic process leading to ALL confirmation. Diffuse T1w hypointensity and diffusion restriction emerged as key imaging findings. A normal CBC should therefore not delay urgent oncologic assessment when the clinical presentation and MRI pattern are suspicious for leukemia.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Nontuberculous mycobacterial infections in patients with hematologic diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64.4 2 [Fundamentals of genetic counseling in hematology: pedigree construction and management of secondary findings in HemeSight®]. [Rinsho ketsueki] The Japanese journal of clinical hematology 49.9 3 Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways. Cancer cell international 51.9 4 Knowledge and awareness of oral cancer and precancerous lesions among patients attending Dhaka Dental College Hospital: a cross-sectional study. BMC oral health 66.4 5 Changes in Body Weight Percentile During Primary Anticancer Treatment in Children: A Retrospective Single-Center Study. Cureus 64.74 6 Erratum: Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis. JCO global oncology 50.74 7 Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib. American journal of clinical pathology 62.42 8 Trachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035. Frontiers in global women's health 38.5 9 From missed diagnosis to lifelong survivorship: a precision oncology roadmap for equity in pediatric and AYA cancer care. Frontiers in oncology 61.8 10 Genomic rearrangements define a distinct biological state in neuroblastoma. Cancer genetics 57.2 11 Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases. World journal of pediatric surgery 71.44 12 A rare cause of dysphagia: A case report on gastroesophageal adenocarcinoma in childhood. JPGN reports 51.9 13 Patterns of high-risk histopathology features of retinoblastoma in enucleated and exenterated eyes at Tikur Anbessa Specialized Hospital: a retrospective study. Cancer treatment and research communications 67.9 14 Pediatric cancer and ethical decision-making: Who speaks for the child? Journal of pediatric nursing 65.3 15 Diagnostic evaluation of long-read nanopore sequencing for pediatric CNS tumors. Acta neuropathologica communications 57.5 16 Preventive Immunomodulatory Effects of Doxycycline and Hyperbaric Oxygen Therapy on Serum Tumor Necrosis Factor-α and Interleukin-6 Levels in a Rat Model of Malaria. Journal of parasitology research 58.44 17 Persistent Pediatric Cervical Lymphadenopathy: A Case Report of Kikuchi-Fujimoto Disease Mimicking Infection and Malignancy. Case reports in pediatrics 50.2 18 Cementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report. Case reports in dentistry 47.5 19 Global, Regional, and National Trends of Pediatric Soft Tissue and Other Extraosseous Sarcomas, 1990 to 2021: A GBD Study. Journal of pediatric hematology/oncology 60.4 20 Breaking the Barrier: MBI-LCBI and Recent Beta-lactam Exposure as Predictors of Piperacillin-Tazobactam Resistance in Pediatric Hemato-oncology Patients. The Pediatric infectious disease journal 69.4 21 Exploiting iron metabolism in Ewing sarcoma. Communications medicine 64.2 22 Unusual [18F]FDOPA PET-CT maging of insulinomas in children. EJNMMI reports 53.0 23 Spontaneous inversion of the left atrial appendage: a first autopsy case report and updated literature review. Cardiology in the young 45.5 24 Prognostic significance of end-of-induction measurable residual disease below 0.01% in pediatric B-lineage acute lymphoblastic leukemia. Cytometry. Part B, Clinical cytometry 65.8 25 Multiple Exposures to Antibiotics Affect Tumor Development in a Mouse Model of Early-Onset Colorectal Cancer. Carcinogenesis 50.9 26 Population-Based Assessment of Cardiometabolic Late Effects in 5-Year Survivors of Pediatric Acute Lymphoblastic Leukemia. Pediatric blood & cancer 69.2 27 Circulating Biomarkers of Disease Burden in Patients With Relapsed or Refractory Neuroblastoma Treated With 131I-MIBG Therapy: A Report From the New Approaches to Neuroblastoma Therapy Consortium. Pediatric blood & cancer 85.43 28 Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy. Pediatric blood & cancer 82.0 29 Surgical Margin and Risk of Local Recurrence in Children and Young Adults With Nonrhabdomyosarcoma Soft Tissue Sarcoma: A Nonrandomized Clinical Trial. JAMA surgery 86.8 30 Enzyme-functionalized β-cyclodextrin silicasomes for sequential stroma remodeling and combination chemotherapy in neuroblastoma. Journal of materials chemistry. B 61.64 31 Undescended Testes in Medically Complex Children: Evaluating A Common Urologic Condition Through a Multi-Disciplinary Lens. The Journal of urology 59.5 32 Brain-sensing synNotch-CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models. Science translational medicine 66.0
PATIENT-FRIENDLY SUMMARY

MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic